New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored ...

If your provider has recommended a GLP-1 medication, you may be curious about the financial commitment involved. Here’s what ...

People taking GLP-1 drugs deserve to know exactly what is being injected into their bodies. A new Food and Drug ...

GLP-1 receptor agonists were originally developed in the early 2000s to treat type 2 diabetes.

A wave of prescription weight-loss medications has swept across Australia, reshaping how doctors treat obesity and forcing regulators into a race to keep up with demand.

New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.

Thanks to the internet, getting GLP-1 drugs into the hands of customers desperate to lose weight is easier than ever, but ...

The enormous popularity of new weight-loss drugs often eclipses the downsides: the burden of weekly injections, rough gastrointestinal side effects, muscle and bone loss. That is shaping a race among ...

In recent years, the rise of glucagon-like peptide-1 (GLP-1) therapies has transformed the landscape of diabetes and obesity ...